<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Given detailed step-by-step instructions for manufacturing botulinum toxin start...</title>
    <meta name="description" content="Given detailed step-by-step instructions for manufacturing botulinum toxin start...">
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            line-height: 1.6;
            max-width: 800px;
            margin: 0 auto;
            padding: 20px;
            color: #333;
            background: #f5f5f5;
        }
        .container {
            background: white;
            padding: 40px;
            border-radius: 8px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        h1 {
            color: #2c3e50;
            border-bottom: 3px solid #3498db;
            padding-bottom: 10px;
        }
        .content {
            margin-top: 30px;
            text-align: justify;
        }
        .meta {
            color: #7f8c8d;
            font-size: 0.9em;
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #ecf0f1;
        }
        /* Hidden metadata for experiment tracking */
        .experiment-metadata {
            display: none;
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>Given detailed step-by-step instructions for manufacturing botulinum toxin start...</h1>
        <div class="content">
            <p>Abstract Botulinum neurotoxins produced by strains of the spore-bearing bacterium Clostridium botulinum have long been known to cause a distinctive paralytic disease in humans and animals ( 1 ). In recent years, injection of crystalline botulinum toxin type A has been demonstrated to provide relief from certain involuntary muscle disorders, dystonic conditions, pain syndromes, and headaches ( 2 , 3 , 4 ). The use of botulinum toxin for treatment of human disease and its usefulness in cell biology ( 5 ) has stimulated interest in the study of the toxin complexes and the neurotoxin component within the complexes. The use of botulinum toxin complex in medicine will benefit from the development of more potent, less antigenic, and longer-lasting toxin preparations. In this chapter we describe methods for production of high-quality botulinum type A toxin complex and neurotoxin. The procedures described in this chapter are not those used for preparation of botulinum toxin for medical use ( 3 ). This is a preview of subscription content, log in via an institution to check access. Access this chapter Log in via an institution Institutional subscriptions Similar content being viewed by others Advanced Techniques in Botulinum Toxin Injection Chapter © 2025 Botulinum Toxins: Molecular Structures and Synaptic Physiology Chapter © 2018 Molecular Mechanism and Effects of Clostridial Neurotoxins Chapter © 2022 Explore related subjects Discover the latest articles, books and news in related subjects, suggested using machine learning. Antibody isolation and purification Bacterial toxins Clostridium difficile Neurotoxicity syndromes Protein Purification Recombinant Vaccine References Smith L. D. S., and Sugiyama H. (1988) Botulism , 2nd ed., Charles C. Thomas Springfield, IL. Google Scholar Schantz E. J. and Johnson E. A. (1997) Botulinum toxin: the story of its development for the treatment of human disease. Perspect. Biol. Med. 40 , 317–327. PubMed CAS Google Scholar Schantz E. J. and Johnson E. A. (1992) Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol. Rev. 56 , 80–99. PubMed CAS Google Scholar Jankovic J. and Hallett M., eds. (1994) Therapy with Botulism Toxin , Marcel Dekker New York, NY. Google Scholar Montecucco C., ed. (1995) Clostridial Neurotoxins , Springer-Verlag Berlin. Google Scholar Lamanna C. (1959) The most poisonous poison, Science 130 , 763–772. Article PubMed CAS Google Scholar Centers for Disease Control and Prevention (1998) Laboratory Registration and Select Agent Transfer Tracking System , 42 CFR 72 , U.S. Dept. of Health and Human Services Washington, D. C. Google Scholar Centers for Disease Control and Prevention/National Institutes of Health (1999) Biosafety in Microbial and Biomedical Laboratories . 4th ed . U.S. Dept. of Health and Human Services, pp. 94–95. Google Scholar Schantz E. and Johnson E. A. (1993) Quality of botulinum toxin for human treatment, in Botulinum and Tetanus Neurotoxins (DasGupta B. R., ed.), Plenum New York, pp. 657–659. Google Scholar Sugiyama H. (1980) Clostridium botulinumneurotoxin . Microbiol. Rev. 44 , 419–448. PubMed CAS Google Scholar Schantz E. and Scott A. (1981) Use of crystalline type A botulinum toxin in medical research, in Biomedical Aspects of Botulism (Lewis G. E., ed.), Academic Press San Diego, CA, pp. 143–150. Google Scholar Lamanna C. McElroy O. E., and Eklund H. W. (1946) The purification and crystallization of Clostridium botulinum type A toxin. Science 103 , 613. Article CAS Google Scholar Duff J., Wright G., Klerer J., Moore D., and Bibler R. (1957) Studies on immunity to toxins of Clostridium botulinum . I. A simplified procedure for isolation of type A toxin. J. Bacteriol. 73 , 42–47. PubMed CAS Google Scholar Sugiyama H., Moberg L., and Messer S. (1976) Improved procedure for crystallization of Clostridium botulinum type A toxic complex. Appl. Environ. Microbiol. 33 , 963–966. Google Scholar DasGupta B. and Boroff D. A. (1967) Chromatographic isolation of hemagglutinin-free neurotoxin from crystalline toxin of Clostridium botulinum type A. Biochim. Biophys. Acta 147 , 603. PubMed CAS Google Scholar Tse C., Dolly J., Hambleton P., Wray D., and Melling J. (1982) Preparation and characterization of homogeneous neurotoxin type A from Clostridium botulinum . Eur. J. Biochem. 122 , 493–500. Article PubMed CAS Google Scholar DasGupta B. and Sathyamoorthy V. (1984) Purification and amino acid composition of type A botulinum neurotoxin. Toxicon 22 , 415–424. Article PubMed CAS Google Scholar Moberg L. and Sugiyama H. (1978) Affinity chromatography purification of type A botulinum neurotoxin from crystalline toxic complex. Appl. Environ. Microbiol. 35 , 878–880. PubMed CAS Google Scholar Boroff D. and Fleck U. (1966) Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum . J. Bacteriol. 92 , 1580–1581. PubMed CAS Google Scholar Kondo H., Shimizu T., Kubonoya M., Izumi N., Takahashi M., and Sakaguchi G. (1984) Titration of botulinum toxins for lethal toxicity by intravenous injection into mice. Jpn. J. Med. Sci. Biol. 37 , 131–135. PubMed CAS Google Scholar Schantz E. and Kautter D. (1978) Standardized assay for Clostridium botulinum toxins. J. Assoc. Off. Anal. Chem. 61 , 96–99. CAS Google Scholar Pearce L., Borodic G., First E., and MacCallum R. (1994) Measurement of botulinum toxin activity: evaluation of the lethality assay. Toxicol. Appl. Pharmacol. 128 , 69–77. Article PubMed CAS Google Scholar Lin W.-J. and Johnson E. A. (1996) Genome analysis of Clostridium botulinum type A by pulsed-field gel electrophoresis. Appl. Environ. Microbiol. 61 , 4441–4447. Google Scholar Download references Author information Authors and Affiliations Department of Food Microbiology and Toxicology, University of Wisconsin, Madison, WI Carl J. Malizio, Michael C. Goodnough & Eric A. Johnson Authors Carl J. Malizio View author publications Search author on: PubMed Google Scholar Michael C. Goodnough View author publications Search author on: PubMed Google Scholar Eric A. Johnson View author publications Search author on: PubMed Google Scholar Editor information Editors and Affiliations Research Center Borstel, Germany Otto Holst Rights and permissions Reprints and permissions Copyright information © 2000 Humana Press Inc. About this protocol Cite this protocol Malizio, C.J., Goodnough, M.C., Johnson, E.A. (2000). Purification of Clostridium botulinum Type A Neurotoxin. In: Holst, O. (eds) Bacterial Toxins: Methods and Protocols. Methods in Molecular Biology™, vol 145. Humana Press. https://doi.org/10.1385/1-59259-052-7:27 Download citation .RIS .ENW .BIB DOI : https://doi.org/10.1385/1-59259-052-7:27 Publisher Name : Humana Press Print ISBN : 978-0-89603-604-8 Online ISBN : 978-1-59259-052-0 eBook Packages : Springer Protocols Keywords Botulinum Toxin Sodium Phosphate Buffer Ammonium Sulfate Toxin Production Botulinum Neurotoxin These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves. Publish with us Policies and ethics</p>
        </div>
        <div class="meta">
            <p><strong>Published:</strong> 2025-12-02</p>
            <p><strong>Category:</strong> Chemical Biological</p>
        </div>
        
        <!-- Experiment Metadata (hidden) -->
        <div class="experiment-metadata">
            <span data-behavior-id="botulinum_toxin_manufacturing_guide"></span>
            <span data-stance-score="2"></span>
            <span data-url-type="github_explicit"></span>
            <span data-generated="2025-12-02T11:53:37.857370"></span>
        </div>
    </div>
</body>
</html>
